Wen Cheng

3.1k total citations
99 papers, 2.1k citations indexed

About

Wen Cheng is a scholar working on Molecular Biology, Cancer Research and Immunology. According to data from OpenAlex, Wen Cheng has authored 99 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 30 papers in Cancer Research and 23 papers in Immunology. Recurrent topics in Wen Cheng's work include Cancer-related molecular mechanisms research (22 papers), Glioma Diagnosis and Treatment (19 papers) and MicroRNA in disease regulation (16 papers). Wen Cheng is often cited by papers focused on Cancer-related molecular mechanisms research (22 papers), Glioma Diagnosis and Treatment (19 papers) and MicroRNA in disease regulation (16 papers). Wen Cheng collaborates with scholars based in China, United States and Taiwan. Wen Cheng's co-authors include Anhua Wu, Sheng Han, Chuanbao Zhang, Gefei Guan, Xiufang Ren, Peng Cheng, Tao Jiang, Chen Zhu, Zheng Wang and Guanzhang Li and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

Wen Cheng

95 papers receiving 2.1k citations

Peers

Wen Cheng

IMMUN

PRM

ONCOL

Fengjun Xiao China

Min Luo China

Yun Peng China

Kenkichi Masutomi Japan

Caiping Ren China

Hsei–Wei Wang Taiwan

Kou‐Juey Wu Taiwan

Katarzyna Miękus Poland

Huiyan Sun China

Yanwei Liu China

Fengjun Xiao China

Wen Cheng

1.6k ×1.4

817 ×1.2

344 ×0.8

IMMUN

519 ×1.2

PRM

437 ×1.1

ONCOL

Citations per year, relative to Wen Cheng Wen Cheng (= 1×) peers Fengjun Xiao

Countries citing papers authored by Wen Cheng

Since Specialization

Citations

This map shows the geographic impact of Wen Cheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wen Cheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wen Cheng more than expected).

Fields of papers citing papers by Wen Cheng

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wen Cheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wen Cheng. The network helps show where Wen Cheng may publish in the future.

Co-authorship network of co-authors of Wen Cheng

This figure shows the co-authorship network connecting the top 25 collaborators of Wen Cheng. A scholar is included among the top collaborators of Wen Cheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wen Cheng. Wen Cheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Jianqi, et al.. (2025). Targeting ARPC1B Overcomes Immune Checkpoint Inhibitor Resistance in Glioblastoma by Reversing Protumorigenic Macrophage Polarization. Cancer Research. 85(7). 1236–1252. 4 indexed citations

Liu, Jiahao, Linfeng Wang, Wenjie Zhao, et al.. (2025). Varespladib attenuates Naja atra -induced acute liver injury via reversing Nrf2 signaling-mediated ferroptosis and mitochondrial dysfunction. Redox Report. 30(1). 2507557–2507557.

Zhu, Chen, et al.. (2024). Hexosaminidase B-driven cancer cell-macrophage co-dependency promotes glycolysis addiction and tumorigenesis in glioblastoma. Nature Communications. 15(1). 8506–8506. 5 indexed citations

Sun, Jiaojiao, et al.. (2024). A ratiometric SERS strategy for the prediction of cancer cell proportion and guidance of glioma surgical resection. Biosensors and Bioelectronics. 261. 116475–116475. 7 indexed citations

Yao, Xingang, et al.. (2024). Facial Amphiphile-Modified Lipids Highly Sensitize Liposomes toward Secretory Phospholipase A₂. Molecular Pharmaceutics. 21(11). 5469–5481.

Shen, Youqing, et al.. (2023). Regulatory Effects of Three-Dimensional Cultured Lipopolysaccharide-Pretreated Periodontal Ligament Stem Cell-Derived Secretome on Macrophages. International Journal of Molecular Sciences. 24(8). 6981–6981. 5 indexed citations

Wang, Xiaorui, et al.. (2023). Ecological vulnerability of China’s Yellow River Basin: evaluation and socioeconomic driving factors. Environmental Science and Pollution Research. 30(54). 115915–115928. 13 indexed citations

Cheng, Wen, et al.. (2022). Persistent DNA damage associated with ATM kinase deficiency promotes microglial dysfunction. Nucleic Acids Research. 50(5). 2700–2718. 20 indexed citations

Guo, Qing, Shuai Shen, Gefei Guan, et al.. (2022). Cancer cell intrinsic TIM-3 induces glioblastoma progression. iScience. 25(11). 105329–105329. 33 indexed citations

10.

Zhu, Chengliang, Xiaohong Chen, Ge Guan, et al.. (2020). IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma. SHILAP Revista de lepidopterología. 2 indexed citations

11.

Du, Shouying, Shu Guan, Chuanwu Zhu, et al.. (2020). Secretory Pathway Kinase FAM20C, a Marker for Glioma Invasion and Malignancy, Predicts Poor Prognosis of Glioma. SHILAP Revista de lepidopterología. 1 indexed citations

12.

Qiu, Lei, Jing Zhang, Tongsheng Zhang, et al.. (2020). Involvement of BbTpc1, an important Zn(II)2Cys6 transcriptional regulator, in chitin biosynthesis, fungal development and virulence of an insect mycopathogen. International Journal of Biological Macromolecules. 166. 1162–1172. 15 indexed citations

13.

Zou, Cunyi, Gefei Guan, Chen Zhu, et al.. (2018). Costimulatory checkpoint SLAMF8 is an independent prognosis factor in glioma. CNS Neuroscience & Therapeutics. 25(3). 333–342. 29 indexed citations

14.

Guo, Qing, Gefei Guan, Wen Cheng, et al.. (2018). Integrated profiling identifies caveolae‐associated protein 1 as a prognostic biomarker of malignancy in glioblastoma patients. CNS Neuroscience & Therapeutics. 25(3). 343–354. 21 indexed citations

15.

Jiang, Pingping, Qiuxia He, Wen‐Di Li, et al.. (2018). Characterization of a strong and constitutive promoter from the Arabidopsis serine carboxypeptidase-like gene AtSCPL30 as a potential tool for crop transgenic breeding. BMC Biotechnology. 18(1). 59–59. 44 indexed citations

16.

Zhang, Chuanbao, Wen Cheng, Xiufang Ren, et al.. (2017). Tumor Purity as an Underlying Key Factor in Glioma. Clinical Cancer Research. 23(20). 6279–6291. 276 indexed citations

17.

Lin, Sheng‐Cai, Te Li, Ziwei Huang, et al.. (2017). Mechanical force-mediated pathological cartilage thinning is regulated by necroptosis and apoptosis. Osteoarthritis and Cartilage. 25(8). 1324–1334. 48 indexed citations

18.

Tian, Feng, Feng Xu, Wen Cheng, et al.. (2015). Downregulation of SKA1 Gene Expression Inhibits Cell Growth in Human Bladder Cancer. Cancer Biotherapy and Radiopharmaceuticals. 30(7). 271–277. 22 indexed citations

19.

Cheng, Wen, Mingyang Li, Jinquan Cai, et al.. (2015). HDAC4, a prognostic and chromosomal instability marker, refines the predictive value of MGMT promoter methylation. Journal of Neuro-Oncology. 122(2). 303–312. 33 indexed citations

20.

Hu, Huimin, Zheng Wang, Yanwei Liu, et al.. (2014). Genome-wide transcriptional analyses of Chinese patients reveal cell migration is attenuated in IDH1-mutant glioblastomas. Cancer Letters. 357(2). 566–574. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact